Entity Common Stock, Shares Outstanding of ADMA BIOLOGICS, INC. from 28 Oct 2011 to 20 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ADMA BIOLOGICS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 28 Oct 2011 to 20 Feb 2026.
  • ADMA BIOLOGICS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 20 Feb 2026 was 238,159,176, a 0.23% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ADMA BIOLOGICS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 238,159,176 +544,076 +0.23% 20 Feb 2026 10-K 25 Feb 2026 2025 FY
Q3 2025 237,997,765 +1,607,512 +0.68% 03 Nov 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 238,630,719 +5,547,892 +2.4% 01 Aug 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 237,615,100 +5,805,903 +2.5% 10 Mar 2025 10-K 18 Mar 2025 2024 FY
Q3 2024 236,390,253 +10,422,585 +4.6% 01 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 233,082,827 +8,176,401 +3.6% 02 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 231,809,197 +9,653,572 +4.3% 03 May 2024 10-Q 09 May 2024 2024 Q1
Q3 2023 225,967,668 +29,190,360 +15% 03 Nov 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 224,906,426 +28,549,277 +15% 04 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 222,155,625 +26,235,272 +13% 17 Mar 2023 10-K 23 Mar 2023 2022 FY
Q3 2022 196,777,308 +963,491 +0.49% 04 Nov 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 196,357,149 +63,587,678 +48% 05 Aug 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 195,920,353 +74,644,996 +62% 18 Mar 2022 10-K 24 Mar 2022 2021 FY
Q3 2021 195,813,817 +101,265,765 +107% 05 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 132,769,471 +46,419,490 +54% 06 Aug 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 121,275,357 +34,930,044 +40% 16 Mar 2021 10-K 25 Mar 2021 2020 FY
Q3 2020 94,548,052 +35,229,697 +59% 02 Nov 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 86,349,981 +27,032,175 +46% 03 Aug 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 86,345,313 +39,992,245 +86% 10 Mar 2020 10-K 13 Mar 2020 2019 FY
Q3 2019 59,318,355 +12,967,112 +28% 01 Nov 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 59,317,806 +12,968,292 +28% 06 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 46,353,068 +1,035,824 +2.3% 11 Mar 2019 10-K 13 Mar 2019 2018 FY
Q3 2018 46,351,243 +20,557,839 +80% 05 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 46,349,514 +20,556,110 +80% 10 Aug 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 45,317,244 +32,430,503 +252% 09 Mar 2018 10-K 29 Mar 2018 2017 FY
Q3 2017 25,793,404 +12,906,663 +100% 01 Nov 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 25,793,404 +12,906,663 +100% 11 Aug 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 12,886,741 +2,173,654 +20% 24 Feb 2017 10-K 24 Feb 2017 2016 FY
Q3 2016 12,886,741 +2,173,654 +20% 10 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 12,886,741 +2,181,168 +20% 12 Aug 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 10,713,087 +1,421,264 +15% 23 Mar 2016 10-K 23 Mar 2016 2015 FY
Q3 2015 10,713,087 +1,421,264 +15% 10 Nov 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 10,705,573 +1,413,750 +15% 10 Aug 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 9,291,823 0 0% 06 Mar 2015 10-K 09 Mar 2015 2014 FY
Q3 2014 9,291,823 +67,880 +0.74% 07 Nov 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 9,291,823 +3,420,821 +58% 11 Aug 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 9,291,823 +4,668,992 +101% 28 Mar 2014 10-K 28 Mar 2014 2013 FY
Q3 2013 9,223,943 +4,601,112 +100% 12 Nov 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 5,871,002 +1,216,699 +26% 12 Aug 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 4,622,831 -31,472 -0.68% 05 Mar 2013 10-K 06 Mar 2013 2012 FY
Q3 2012 4,622,831 +2,122,831 +85% 12 Nov 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 4,654,303 13 Aug 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 4,654,303 14 May 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 2,500,000 31 Jan 2012 10-Q 01 Feb 2012 2012 Q2
Q3 2011 2,500,000 28 Oct 2011 10-Q 28 Oct 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.